Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $4.1 million.

  • Beta Bionics' Change in Accured Expenses rose 24291.67% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2024, which is 27468.49% up from last year.
  • Per Beta Bionics' latest filing, its Change in Accured Expenses stood at $4.1 million for Q3 2025, which was up 24291.67% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Change in Accured Expenses ranged from a high of $4.1 million in Q3 2025 and a low of -$5.3 million during Q1 2025